Sylvain Mareschal, Ph.D.
Bioinformatics postdoc
September 14, 2014 at 09:00
Dubois et al, SOHO 2014
Related entries:
Second Annual Meeting of the Society of Hematologic Oncology (Houston, Texas, USA)

EZH2-Activating Mutations in DLBCL Are Easily Predictable by Routine Immunohistochemistry Analysis: a Tool to More Efficiently Define EZH2 Inhibitor-Sensitive Patients ?

Dubois S, Mareschal S, Cornic M, Picquenot JM, Bohers E, Alcantara M, Maingonnat C, Bertrand P, Ruminy P, Bastard C, Tilly H, Jardin F